Genetic Risk Factors Are Not Associated with Wet Age-Related Macular Degeneration Treatment Response to Ranibizumab

被引：0
|
作者：
Chaudhary, Varun [1 ]
Brent, Michael [2 ]
Lam, Wai-Ching [2 ]
Devenyi, Robert [2 ]
Teichman, Joshua [1 ]
Mak, Michael Ying-Kit [2 ]
Kaur, Harneel [1 ]
Barbosa, Joshua [1 ]
Carter, Ronald [4 ]
Farrokhyar, Forough [3 ]
机构：
[1] McMaster Univ, Hamilton Reg Eye Inst, Dept Surg, Div Ophthalmol, Hamilton, ON, Canada
[2] Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada
[3] McMaster Univ, Dept Surg, Hamilton, ON, Canada
[4] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada
来源：
OPHTHALMOLOGICA | 2018年 / 239卷 / 04期
关键词：
D O I：
10.1159/000481178
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：240 / 240
页数：1
相关论文
共 50 条
  • [41] A safety evaluation of ranibizumab in the treatment of age-related macular degeneration
    Gibson, Jonathan Mark
    Gibson, Stewart James
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (09) : 1259 - 1270
  • [42] Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
    Martin, Daniel F.
    Maguire, Maureen G.
    Fine, Stuart L.
    Ying, Gui-shuang
    Jaffe, Glenn J.
    Grunwald, Juan E.
    Toth, Cynthia
    Redford, Maryann
    Ferris, Frederick L., III
    OPHTHALMOLOGY, 2012, 119 (07) : 1388 - 1398
  • [43] Cost Comparison of Intravitreal Aflibercept With Bevacizumab and Ranibizumab for the Treatment of Wet Age-Related Macular Degeneration
    Shaikh, Adeel H.
    Toussaint, Brian W.
    Miller, Daniel M.
    Petersen, Michael R.
    Foster, Robert E.
    Riemann, Christopher D.
    Hutchins, Robert K.
    Sisk, Robert A.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2015, 46 (01): : 62 - 66
  • [44] Ranibizumab: treatment in patients with neovascular age-related macular degeneration
    Pieramici, Dante J.
    Avery, Robert L.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (11) : 1237 - 1245
  • [45] Ranibizumab according to need: A treatment for age-related macular degeneration
    Spaide, Richard
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 143 (04) : 679 - 680
  • [46] Pegaptanib in the treatment of wet, age-related macular degeneration
    Vinores, Stanley A.
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2006, 1 (03): : 263 - 268
  • [47] Bevasiranib for the Treatment of Wet, Age-Related Macular Degeneration
    Garba, Adinoyi O.
    Mousa, Shaker A.
    OPHTHALMOLOGY AND EYE DISEASES, 2010, 2 : 75 - 83
  • [48] Controversies in the treatment of wet age-related macular degeneration
    Moreno, Sandra Flores
    Paloma, Javier Bautista
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2008, 145 (05) : 937 - 937
  • [49] Ranibizumab for neovascular age-related macular degeneration
    Rosenfeld, Philip J.
    Brown, David M.
    Heier, Jeffrey S.
    Boyer, David S.
    Kaiser, Peter K.
    Chung, Carol Y.
    Kim, Robert Y.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14): : 1419 - 1431
  • [50] Efficacy and safety of ranibizumab for wet age-related macular degeneration in Chinese patients
    Qi, Hui-Jun
    Li, Xiao-Xin
    Zhang, Jun-Yan
    Zhao, Ming-Wei
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2017, 10 (01) : 91 - 97
12345